Rapid engraftment of human ALL in NOD/SCID mice involves deficient apoptosis signaling

Cell Death and Disease

Volumn 3, Issue 8, 2012, Pages

  Queudeville, M ^a   Seyfried, F ^a   Eckhoff, S M ^a   Trentin, L ^a   Ulrich, S ^a   Schirmer, M ^a   Debatin, K M ^a   Meyer, L H ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Acute lymphoblastic leukemia; Apoptosis signaling; NOD SCID; Prognosis; Xenograft model

Indexed keywords

APOPTOSOME; CASPASE 3; CYTOCHROME C; DEATH ASSOCIATED PROTEIN KINASE; DEATH ASSOCIATED PROTEIN KINASE K1; PREDNISONE; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER MODEL; CANCER PATIENT; CANCER REGRESSION; CANCER RELAPSE; CANCER SURVIVAL; CELL LEVEL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG RESPONSE; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; INFANT; INTRACELLULAR SIGNALING; LEUKEMIA CELL; MALE; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; OVERALL SURVIVAL; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN FUNCTION; SCHOOL CHILD; SCID MOUSE; TUMOR ENGRAFTMENT;

ADOLESCENT; ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; APOPTOSOMES; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES; CASPASE 3; CHILD; CHILD, PRESCHOOL; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 4; CYTOCHROMES C; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INFANT; LEUKEMIA, MYELOID, ACUTE; MALE; MICE; MICE, INBRED NOD; MICE, SCID; PHENOTYPE; RECURRENCE; SIGNAL TRANSDUCTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

MUS;

EID: 84865772044     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2012.107     Document Type: Article

References (40)

1. Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med 2006; 354: 166-178. (Pubitemid 43076714)
2. Schrappe M, Reiter A, Ludwig WD, Harbott J, Zimmermann M, Hiddemann W et al. Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group. Blood 2000; 95: 3310-3322. (Pubitemid 30428458)
3. Henze G, Fengler R, Hartmann R, Kornhuber B, Janka-Schaub G, Niethammer D et al. Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia. Blood 1991; 78: 1166-1172.
4. Conter V, Bartram CR, Valsecchi MG, Schrauder A, Panzer-Grumayer R, Moricke A et al. Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study. Blood 2010; 115: 3206-3214.
5. Meyer LH, Eckhoff SM, Queudeville M, Kraus JM, Giordan M, Stursberg J et al. Early relapse in all is identified by time to leukemia in nod/scid mice and is characterized by a gene signature involving survival pathways. Cancer Cell 2011; 19: 206-217.
6. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-674.
7. Suminoe A, Matsuzaki A, Hattori H, Koga Y, Kinukawa N, Ishii E et al. mRNA expression of apoptosis-associated genes in infant acute lymphoblastic leukemia: low Fas expression is an independent predictor for poor prognosis. Leukemia 2004; 18: 365-368. (Pubitemid 38240059)
8. Del Poeta G, Venditti A, Del Principe MI, Maurillo L, Buccisano F, Tamburini A et al. Amount of spontaneous apoptosis detected by Bax/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML). Blood 2003; 101: 2125-2131. (Pubitemid 36302046)
9. Deiss LP, Feinstein E, Berissi H, Cohen O, Kimchi A. Identification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the gamma interferon-induced cell death. Genes Dev 1995; 9: 15-30.
10. Jiang X, Li J, Paskind M, Epstein PM. Inhibition of calmodulin-dependent phospho-diesterase induces apoptosis in human leukemic cells. Proc Natl Acad Sci USA 1996; 93: 11236-11241. (Pubitemid 26333147)
11. Meyer LH, Karawajew L, Schrappe M, Ludwig WD, Debatin KM, Stahnke K. Cytochrome c-related caspase-3 activation determines treatment response and relapse in childhood precursor B-cell ALL. Blood 2006; 107: 4524-4531. (Pubitemid 43801381)
12. Meyer LH, Queudeville M, Eckhoff SM, Creutzig U, Reinhardt D, Karawajew L et al. Intact apoptosis signaling in myeloid leukemia cells determines treatment outcome in childhood AML. Blood 2008; 111: 2899-2903.
13. Lock RB, Liem N, Farnsworth ML, Milross CG, Xue C, Tajbakhsh M et al. The nonobese diabetic/severe combined immunodeficient (NOD/SCID) mouse model of childhood acute lymphoblastic leukemia reveals intrinsic differences in biologic characteristics at diagnosis and relapse. Blood 2002; 99: 4100-4108. (Pubitemid 35332053)
14. Nijmeijer BA, Mollevanger P, van Zelderen-Bhola SL, Kluin-Nelemans HC, Willemze R, Falkenburg JH. Monitoring of engraftment and progression of acute lymphoblastic leukemia in individual NOD/SCID mice. Exp Hematol 2001; 29: 322-329. (Pubitemid 32220124)
15. Notta F, Mullighan CG, Wang JC, Poeppl A, Doulatov S, Phillips LA et al. Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells. Nature 2011; 469: 362-367.
16. Schmitz M, Breithaupt P, Scheidegger N, Cario G, Bonapace L, Meissner B et al. Xenografts of highly resistant leukemia recapitulate the clonal composition of the leukemogenic compartment. Blood 2011; 118: 1854-1864.
17. Yeoh EJ, Ross ME, Shurtleff SA, Williams WK, Patel D, Mahfouz R et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 2002; 1: 133-143. (Pubitemid 41039160)
18. Armstrong SA, Staunton JE, Silverman LB, Pieters R, den Boer ML, Minden MD et al. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet 2002; 30: 41-47.
19. Salomons GS, Smets LA, Verwijs-Janssen M, Hart AA, Haarman EG, Kaspers GJ et al. Bcl-2 family members in childhood acute lymphoblastic leukemia: relationships with features at presentation, in vitro and in vivo drug response and long-term clinical outcome. Leukemia 1999; 13: 1574-1580. (Pubitemid 29465620)
20. Wuchter C, Karawajew L, Ruppert V, Schrappe M, Harbott J, Ratei R et al. Constitutive expression levels of CD95 and Bcl-2 as well as CD95 function and spontaneous apoptosis in vitro do not predict the response to induction chemotherapy and relapse rate in childhood acute lymphoblastic leukaemia. Br J Haematol 2000; 110: 154-160. (Pubitemid 30625603)
21. Ong YL, McMullin MF, Bailie KE, Lappin TR, Jones FG, Irvine AE. High bax expression is a good prognostic indicator in acute myeloid leukaemia. Br J Haematol 2000; 111: 182-189.
22. Tamm I, Richter S, Oltersdorf D, Creutzig U, Harbott J, Scholz F et al. High expression levels of x-linked inhibitor of apoptosis protein and survivin correlate with poor overall survival in childhood de novo acute myeloid leukemia. Clin Cancer Res 2004; 10: 3737-3744. (Pubitemid 38697607)
23. Schaich M, Illmer T, Seitz G, Mohr B, Schakel U, Beck JF et al. The prognostic value of Bcl-XL gene expression for remission induction is influenced by cytogenetics in adult acute myeloid leukemia. Haematologica 2001; 86: 470-477. (Pubitemid 33638974)
24. Choi J, Hwang YK, Sung KW, Lee SH, Yoo KH, Jung HL et al. Expression of Livin, an antiapoptotic protein, is an independent favorable prognostic factor in childhood acute lymphoblastic leukemia. Blood 2007; 109: 471-477. (Pubitemid 46105940)
25. Carter BZ, Kornblau SM, Tsao T, Wang RY, Schober WD, Milella M et al. Caspase-independent cell death in AML: caspase inhibition in vitro with pan-caspase inhibitors or in vivo by XIAP or Survivin does not affect cell survival or prognosis. Blood 2003; 102: 4179-4186. (Pubitemid 37487005)
26. Tamm I, Kornblau SM, Segall H, Krajewski S, Welsh K, Kitada S et al. Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clin Cancer Res 2000; 6: 1796-1803. (Pubitemid 30305074)
27. Tamm I, Richter S, Scholz F, Schmelz K, Oltersdorf D, Karawajew L et al. XIAP expression correlates with monocytic differentiation in adult de novo AML: impact on prognosis. Hematol J 2004; 5: 489-495. (Pubitemid 40045282)
28. Kohler T, Schill C, Deininger MW, Krahl R, Borchert S, Hasenclever D et al. High Bad and Bax mRNA expression correlate with negative outcome in acute myeloid leukemia (AML). Leukemia 2002; 16: 22-29. (Pubitemid 34105595)
29. Faderl S, Thall P, Kantarjian H, Talpaz M, Harris D, Van Q et al. Caspase 2 and caspase 3 as predictors of complete remission and survival in adults with acute lymphoblastic leukemia. Clin Cancer Res 1999; 5: 4041-4007.
30. Cohen O, Inbal B, Kissil JL, Raveh T, Berissi H, Spivak-Kroizaman T et al. DAP-kinase participates in TNF-alpha- and Fas-induced apoptosis and its function requires the death domain. J Cell Biol 1999; 146:141-148. (Pubitemid 29349970)
31. Inbal B, Cohen O, Polak-Charcon S, Kopolovic J, Vadai E, Eisenbach L et al. DAP kinase links the control of apoptosis to metastasis. Nature 1997; 390:180-184. (Pubitemid 27507988)
32. Holleman A, den Boer ML, de Menezes RX, Cheok MH, Cheng C, Kazemier KM et al. The expression of 70 apoptosis genes in relation to lineage, genetic subtype, cellular drug resistance, and outcome in childhood acute lymphoblastic leukemia. Blood 2006; 107: 769-776. (Pubitemid 43076404)
33. Meyer LH, Debatin KM. Diversity of human leukemia xenograft mouse models: implications for disease biology. Cancer Res 2011; 71: 7141-7144.
34. Baersch G, Mollers T, Hotte A, Dockhorn-Dworniczak B, Rube C, Ritter J et al. Good engraftment of B-cell precursor ALL in NOD-SCID mice. Klin Padiatr1997; 209: 178-185. (Pubitemid 27328966)
35. Borgmann A, Baldy C, von Stackelberg A, Beyermann B, Fichtner I, Nurnberg P et al. Childhood ALL blasts retain phenotypic and genotypic characteristics upon long-term serial passage in NOD/SCID mice. Pediatr Hematol Oncol 2000; 17: 635-650.
36. Kamel-Reid S, Letarte M, Sirard C, Doedens M, Grunberger T, Fulop G et al. A model of human acute lymphoblastic leukemia in immune-deficient SCID mice. Science 1989; 246: 1597-1600. (Pubitemid 20036692)
37. Stahnke K, Mohr A, Liu J, Meyer LH, Karawajew L, Debatin KM. Identification of deficient mitochondrial signaling in apoptosis resistant leukemia cells by flow cytometric analysis of intracellular cytochrome c, caspase-3 and apoptosis. Apoptosis 2004; 9: 457-465. (Pubitemid 38987582)
38. Manabe A, Coustan-Smith E, Behm FG, Raimondi SC, Campana D. Bone marrow-derived stromal cells prevent apoptotic cell death in B-lineage acute lymphoblastic leukemia. Blood 1992; 79: 2370-2377.
39. Campana D, Iwamoto S, Bendall L, Bradstock K. Growth requirements and immunophenotype of acute lymphoblastic leukemia progenitors. Blood 2005; 105: 4150. (Pubitemid 40656171)
40. Abramoff MD, Magalhaes PJ, Ram SJ. Image Processing with Image J. Biophotonics International 2004; 11: 36-42.